BRAF polymorphisms and the risk of ovarian cancer of low malignant potential-Reference-Cited by-同舟云学术

BRAF polymorphisms and the risk of ovarian cancer of low malignant potential

Published:2005-06 Issue:3 Volume:97 Page:807-812
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kelemen Livia,James Michael,Spurdle Amanda,Campbell Ian,Chang-Claude Jenny,Peel David,Anton-Culver Hoda,Berchuck Andrew,Schildkraut Joellen,Whittemore Alice,McGurie Valerie,DiCioccio Richard A.,Duffy David,Chenevix-Trench Georgia

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference29 articles.

1. Surface epithelial–stromal tumors of the ovary;Russell,1994

2. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis;Shih;Am. J. Pathol.,2004

3. Ovarian tumors of low malignant potential;Trimble;Oncology (Huntingt),2003

4. Borderline ovarian tumours: a review of the recent literature;Crispens;Curr. Opin. Obstet. Gynecol.,2003

5. High frequency of BRAF mutations in nevi;Pollock;Nat. Genet.,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The highs and lows of serous ovarian cancer;Cancer;2023-06-27

2. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets;Advances in Oncology;2023-05

3. Low-grade serous ovarian cancer;Diagnosis and Treatment of Rare Gynecologic Cancers;2023

4. Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum;Current Oncology Reports;2022-08-13

5. Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer;International Journal of Gynecologic Cancer;2014-07